Abstract Weber-Christian Disease (WCD), also known as relapsing febrile lobular non-suppurative panniculitis, is a rare condition characterized by recurrent subcutaneous inXammatory nodules in the adipose tissue in addition to fever, malaise and other systemic manifestations such as polyarthralgia and polymyalgia. The association with small vessel vasculitis has been rarely reported. We report here an unusual case of WCD associated with small vessels vasculitis also describing the eYcacy of Cyclosporin A treatment.
Introduction
Weber-Christian Disease (WCD), also known as relapsing febrile lobular non-suppurative panniculitis, is a rare condition characterized by recurrent subcutaneous inXammatory nodules in the adipose tissue in addition to fever, malaise and other systemic manifestations such as polyarthralgia and polymyalgia; the subcutaneous nodules are painful and mainly observed in the extremities and in the trunk.
Lobular panniculitis is the essential feature in biopsy specimens from the nodules [1, 2] and the association with small vessel vasculitis has been reported only once [3] , in association with an autoinXammatory gene mutation in TNFRSF1A encoding for the p55 tumor necrosis factorreceptor.
WCD may present as idiopathic or secondary to a variety of other conditions, such as connective tissue diseases, lymphomas, leukemia, sarcoidosis and fungal and bacterial infections. The cause of this disease is still unclear, and an immune mechanism has been implicated in the pathogenesis [4] .
We report here a rare case of WCD in a child, associated with small vessel vasculitis; we also describe the good response to Cyclosporine A (Cy A) treatment.
Case report
An 8-year-old boy was Wrst seen in our Unit with an 8-month history of recurrent febrile attacks with painful, palpable, subcutaneous, erythematous nodules localized on the distal extremity of both lower limbs (Fig. 1a) .
Test for antinuclear and anti-DNA antibodies were negative and extensive microbiological and serological investigations were negative for bacteria, fungi, parasites, including Borrelia burgdorferi and Brucella; no signiWcant titers of antiviral antibodies were detected, including antibodies to Cytomegalovirus and EpsteinBarr virus. Erythrocyte sedimentation rate and C-reactive protein were not increased; renal and liver function was normal. Alpha-1-antitrypsin serum levels were within normal limits, and a chest X-ray did not show any abnormality. A skin biopsy was performed and documented a mild lobular panniculitis, with foamy histiocytes and lymphocytes forming perivascular cuYng; isolated multinucleated giant cells were observable. The patient was hence diagnosed with WCD and small vessel vasculitis ( Fig. 2b-d ) and started treatment with prednisone 1 mg/kg/die, gradually tapered and eventually discontinued after 5 months. Corticosteroids determined a reduction in pain and inXammatory features of the skin lesions but did not alter the progression of panniculitis.
The patient therefore started treatment with Cy A at 5 mg/kg/day, and already 1 month later, the cutaneous lesions were stable, not painful nor erythematous, and the patient did not have further febrile episodes. The improvement was conWrmed at a 6-month follow-up (Fig. 1b) , although obviously the depressed lesions from previous inXammation were still evident. 
Discussion
Panniculitis in association with small vessel vasculitis is rare, and to the best of our knowledge has been reported only twice, in association with TNFRSF1A gene mutation [3] and as the initial manifestation of brucellosis [5] .
Our patient underwent genetic testing for mutations in TNFRSF1A gene and other autoinXammatory genes such as MEFV and CIAS1. No mutations were found.
WCD is a primary panniculitis, which is a histiocytic disorder described as a form of lobular panniculitis with inWltration of hemophagocytic benign histiocytes [1] . No speciWc treatment is available for WCD. Corticosteroids have been used without satisfactory results, although they are often eVective to treat acute attacks of the disease.
Two patients successfully treated with thalidomide have been reported, although the question of a possible spontaneous remission remains unanswered [6, 7] .
Successful treatment of WCD with Cy A was Wrst described in 1987 [8] and several additional reports described a similar response [9, 10] .
Cy A has potent immunosuppressive properties that result from selective inhibition of T lymphocyte activation [11] . The patient reported by Lamprecht et al. with panniculitis and vasculitis in the context of TRAPS was successfully treated with the human soluble p75 TNF--receptor fusion protein etanercept.
Our report describes an uncommon association of WCD and small vessel vasculitis, previously described only twice, and conWrms the eYcacy of Cy A in the treatment of WCD. The T cell immune response may be implicated in the pathogenesis of WCD [12] , thus explaining the eYcacy of Cy A in the treatment of this disease.
